Efficacy of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis
Author:
Publisher
Wiley
Subject
Otorhinolaryngology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/lary.21415/fullpdf
Reference11 articles.
1. Thirty years of research into Rendu-Osler-Weber disease in France: historical demography, population genetics, and molecular biology;Brunet;Population Engl Ed,2009
2. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan;Dakeishi;Hum Mutat,2002
3. Hereditary hemorrhagic telangiectasia [HHT]: a population-based study of prevalence and mortality in Danish HHT patients;Kjeldsen;J Intern Med,1999
4. An epistaxis severity score for hereditary hemorrhagic telangiectasia;Hoag;Laryngoscope,2010
5. Diagnostic criteria for hereditary hermorrhagic telangiectasia (Rendu-Osler-Weber syndrome);Shovlin;Am J Med Genet,2000
Cited by 74 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia;Orphanet Journal of Rare Diseases;2022-11-07
2. The Effect of Bevacizumab and Propranolol on Nasal Polyposis;International Journal of Clinical Practice;2022-10-12
3. An in vitro study on the effect of bevacizumab on endothelial cell proliferation and VEGF concentration level in patients with hereditary hemorrhagic telangiectasia;Experimental and Therapeutic Medicine;2022-07-05
4. North American Study for the Treatment of Recurrent Epistaxis with Doxycycline: The NOSTRIL trial;Journal of Thrombosis and Haemostasis;2022-05
5. Randomized, controlled, double‐blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization;International Forum of Allergy & Rhinology;2022-01-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3